Pro re Recent Events: Insiders invested $3M in the tender offer which shows their strong support for, and belief in, the potential of leronlimab.
Con re Recent Events: The CEO has consistently over promised, and under delivered, the last time being on the investor call.
I continue to believe the company would flourish if Pourhassan were to be replaced with a seasoned CEO who is able to deliver on his or her promises.
LM
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-
The Lawman

style="color:red">The Lawman

"color:red">The Lawman

:red">The Lawman

The Lawman

span>Lawman

awman

img]